Literature DB >> 12791705

Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension.

Koji Ito1, Yoshitaka Hirooka, Koji Sakai, Takuya Kishi, Kozo Kaibuchi, Hiroaki Shimokawa, Akira Takeshita.   

Abstract

Recent studies have demonstrated that the Rho/Rho-kinase pathway plays an important role in various cellular functions, including actin cytoskeleton organization and vascular smooth muscle contraction. This pathway is also present in the central nervous system and is involved in the maintenance of dendritic spines and axon outgrowth and in the regulation of neurotransmitter release. However, its role in central blood pressure regulation is unknown. In the present study, blockade of the Rho/Rho-kinase pathway in the nucleus tractus solitarii (NTS) of the brain stem by microinjection of a specific Rho-kinase inhibitor decreased blood pressure, heart rate, and renal sympathetic nerve activity in both Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR). However, the magnitude of decreases in these variables was greater in SHR than in WKY rats. In addition, an adenovirus vector encoding dominant-negative Rho-kinase decreased blood pressure, heart rate, and urinary norepinephrine excretion in both WKY rats and SHR in an awake and free-moving state. The magnitude of decreases in these variables was also greater in SHR than in WKY rats. Furthermore, membrane RhoA expression and Rho-kinase activity in the NTS were enhanced in SHR compared with WKY rats. These observations indicate that the Rho/Rho-kinase pathway in the NTS contributes to blood pressure regulation via the sympathetic nervous system in vivo and suggest that activation of this pathway is involved in the central mechanisms of hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791705     DOI: 10.1161/01.RES.0000079941.59846.D4

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

Review 1.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

2.  Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state.

Authors:  Matthew E Kutcher; Alexey Y Kolyada; Howard K Surks; Ira M Herman
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

Review 3.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 4.  Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Small GTPases       Date:  2014-10-31

5.  The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.

Authors:  Hui-Hsuan Chung; Zen-Kong Dai; Bin-Nan Wu; Jwu-Lai Yeh; Chee-Yin Chai; Koung-Shing Chu; Chung-Pin Liu; Ing-Jun Chen
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 6.  Rho kinase as a therapeutic target in cardiovascular disease.

Authors:  Michelle Surma; Lei Wei; Jianjian Shi
Journal:  Future Cardiol       Date:  2011-09

7.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

Review 8.  Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?

Authors:  James K Liao
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

9.  Central Angiotensin-II Increases Blood Pressure and Sympathetic Outflow via Rho Kinase Activation in Conscious Rabbits.

Authors:  Peter R Pellegrino; Alicia M Schiller; Karla K V Haack; Irving H Zucker
Journal:  Hypertension       Date:  2016-09-26       Impact factor: 10.190

10.  Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Salim Yalcin Inan; Burak Cem Soner; Ayse Saide Sahin
Journal:  Metab Brain Dis       Date:  2016-03-21       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.